Expert Views
Don't sell & run away, December may be better than November
We have had extremely good volumes, over Rs 60,000 crore in a single day. I expect it to go even higher, says Deepak Shenoy.
Wockhardt in talks with a number of vaccine manufacturers
Manufacturing of vaccines is a big opportunity for Indian pharmaceutical industry, says Habil Khorakiwala. Wockhardt is in partmership with UK govt to manufacture Covid-19 vaccine .
Two-wheeler industry showing 10% decline, mostly at entry level
Bajaj Auto experienced double digit growth but as you move down the pyramid and ride to the entry level, it goes into a decline, says Rakesh Sharma.
How Samir Arora & Raamdeo Agrawal learnt from their mistakes
Market gurus on biggest learnings from the mistakes they have made.
Sustainable demand in auto will start picking up in Q4
Tractors and passenger vehicles lead retail momentum in auto. Commercial vehicles are recovering fast but still may be flattish to down on a year-on-year basis, says Jay Kale.
Look beyond largecaps, dig deeper in pharma & IT
From July-August, we have seen a steady re-rating in the small and midcaps which should accelerate into next year, says Hiren Ved.
BULL'S EYE
RJ's wealth swells to Rs 14,000 cr: Check the top performers
Rakesh Jhunjhunwala's equity portfolio is worth 14,147 crore today, which almost equals his June
Samir Arora on why investing in infra stocks was a mistake
Stocks of infrastructure companies have become some of the biggest wealth destroyers on Dalal Str
How India Inc managed a 9-10% earnings upgrade
All key sectors, barring capital goods and utilities, reported expansion in operating margins.
Bitcoin’s rebound puts $20,000 level as next big test
Bitcoin was trading at about $19,410 as of 3:40 p.m. in Tokyo. The broader Bloomberg Galaxy Cry
This high-flying PSU stock has more steam left
A month ago, the stock had 12 ‘strong buy’ and 10 ‘buy’ recommendations.
What makes Mark Mobius so bullish on India?
Biden, 77, is all set to become the 46th President of the United States, while Senator Kamala Har
Is bitcoin the new gold? Here's what Analysts say
A leaked report from Citibank, titled ‘Bitcoin: 21st Century Gold’ said the price of the bitcoin
Post 100% rise, should you still buy top Nifty gainers?
Five of these stocks have consensus ‘buy’, two have 'hold' while one an ‘underperform’ ratings no
Nifty firms manage to report best-ever profits for Q2
Cost reduction, better-than-expected demand recovery and lower provisions for financial firms are
Market Movers
Markets Videos
What markets can expect in December
In terms of events, December could be a much more subdued and docile month with no significant events or triggers on the horizon, says Kunj Bansal.
What to buy as the rally gets broader
FII money will target the large cap stocks and that will make the index move up once again, says Sudip Bandyopadhyay.
3 cements stocks to buy cutting across market caps
We prefer UltraTech as a large cap top pick followed by JK Cement in the midcap space and ACC as a value pick, says Siddhartha Khemka.
Start accumulating Reliance if it falls below Rs 2,000
Any good correction will be an opportunity to buy RIL from an investment perspective, says Siddhartha Khemka.
Pharma, chemical stocks could consolidate over next 3 months
Longer term, pharma and chemicals is a very structural story underlying these businesses and probably they will do very well, says Pankaj Murarka.
Bank stocks are nearing overbought territory
‘There is a higher chance that the Nifty would remain more or less in the range 13,200 to 12,800’
Worst is over! By Q4, 2.5% positive growth likely: Kaushik Das
In Q3, we could end up with minus 1.5% and if we are lucky we can even get a positive number.
Positive GDP number not likely before next financial year
I am not confident that incrementally Q3 numbers will be proportionately better. A positive number can be expected only in the next financial year, says Siddhartha Sanyal
DIIs may now divert their money from largecaps to midcaps and smallcaps: Nirmal Jain
The low interest rate has a big role in reviving growth and I only hope that RBI and the government maintain benign liquidity and in a falling interest rates scenario,says the Chairman & CEO, IIFL Finance.
IGL may have to hike prices marginally after PNGRB directive
The directive has implications from an investment standpoint as the incumbent CGDs will have to spend more aggressively to protect their market share against whatever third parties or OMCs might be looking to grab, says Probal Sen.
